Our Product

Vitamin/Mineral Micronutrient Supplement for Children and Adults on the Spectrum**

Cerecell Spectrum AC1 Enhanced Nutritional Supplementation Powder


Spectrum AC1
Enhanced Nutritional Supplementation
Powder

Up to 8 Weeks of Daily Servings
47.44 g

$84.00 - or subscribe and save up to 15%

Cerecell Spectrum AC2 Enhanced Nutritional Supplementation Powder


Spectrum AC2
Enhanced Nutritional Supplementation
Capsules

Up to 8 Weeks of Daily Servings
56 Capsules

$84.00 - or subscribe and save up to 15%

Cerecell Spectrum AC1 Starter Enhanced Nutritional Supplementation Powder
Trial Size

Spectrum AC1 Starter
Enhanced Nutritional Supplementation
Powder

21/30-Day Trial
15.25 g

$27.00  $10.00

Cerecell Spectrum AC2 Starter Enhanced Nutritional Supplementation Powder
Trial Size

Spectrum AC2 Starter
Enhanced Nutritional Supplementation
Capsules

21/30-Day Trial
18 Capsules

$27.00  $10.00

** These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, cure or prevent any disease.

Cerecell is to be used only as an adjunctive supplement. It is not to be used as a replacement or alternative to FDA-approved treatments for ASD, CPAE, PANDAS, or PANS. Please consult with your pediatrician or primary care provider to determine whether this supplement is a good fit for your child.

Note: The information presented on this site is for educational purposes only and is not intended to replace advice from your physician or other health care professional or any information found on any product label or packaging. You should always consult with a qualified health care professional before starting any exercise, diet or supplement regimen.

Cerecell recommends that FDA-approved treatments for autism, including Occupational Therapy, Feeding Therapy, Speech Therapy, ABA, Music Therapy, and any other FDA-approved modalities implemented by the patient’s provider, should be used as the first line of treatment.

For CPAE, PANDAS, and PANS, Cerecell endorses all standard FDA therapies as directed by the University of Arizona CPAE clinic, under the Steele Center, considering them the Gold Standard for treating children with these conditions.

Dr. Spiekerman, of Arcadia Pediatric Consulting, is an owner of Cerecell, a division of Arcadia Therapeutics Corp., and stands to gain financially from its sale.

Pin It on Pinterest

0
    0
    Your Cart
    Your cart is emptyReturn to Shop
        Skip to content